An Uncommon Case of Dulaglutide-Related Morbilliform Drug Eruption

Autor: Kyriakos, Georgios Diamantis, Evangelos Memi, Eleni and Elefsiniotis, Ioannis

Dulaglutide is a once-weekly injectable glucagon-like peptide-1 (GLP-1) receptor agonist that has shown a durable glycemic efficacy as well as beneficial effects on body weight and major adverse cardiovascular events (MACE) outcomes, making it an imp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::34483c44408e33e27557137d306cbd1c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3034179

Contributors

Autor: Abbott, David H., Altieri, Paola, Anagnostis, Panagiotis, Antoniou-Tsigkos, Athanasios, Armeni, Eleni, Balen, Adam H., Barber, Thomas M., Benvenga, Salvatore, Carmina, Enrico, Cecchetti, Carolina, Crisosto, Nicolás, Di Bari, Flavia, Diamanti-Kandarakis, Evanthia, Dinicola, Simona, Escobar-Morreale, Héctor F., Fanelli, Flaminia, Fighera, T.M., Forte, Gianpiero, Gambineri, Alessandra, Georgescu, Carmen Emanuela, Georgopoulos, Neoklis A., Goulis, Dimitrios G., Greinwald, Emily P., Kahal, Hassan, Kandaraki, Eleni, Kyrou, Ioannis, Lambrinoudaki, Irene, Lecke, S.B., Levine, Jon E., Marchesan, L.B., Markantes, Georgios K., Mascarenhas, Mariano, Mastorakos, George, Memi, Eleni, Moghetti, Paolo, Monastra, Giovanni, Oguz, Seda Hanife, Pagotto, Uberto, Papadimitriou, Kasiani, Papalou, Olga, Pastroma, Konstantina, Pereira, Sofia S., Pignatelli, Duarte, Preiato, Valentina Lo, Randeva, Harpal S., Ribichini, Danilo, Santos, B.R., Sendur, Suleyman Nahit, Spritzer, P.M., Tilotta, Marco, Tsichlia, Gina, Unfer, Vittorio, Unluturk, Ugur, Vrachnis, Nikolaos, Weickert, Martin O., Yildiz, Bulent Okan

Publikováno v: In Polycystic Ovary Syndrome 2022:xi-xiii

SGLT2 Inhibitors and Cardiovascular Outcomes: Do They Differ or There is a Class Effect? New Insights from the EMPA-REG OUTCOME trial and the CVD-REAL Study

Autor: Kyriakos, Georgios, Quiles-Sanchez, Lourdes V., Garmpi, Anna, Farmaki, Paraskevi, Kyre, Konstantina, Savvanis, Spyridon, Antoniou, Vasileios K., Memi, Eleni

Publikováno v: Current Cardiology Reviews; November 2020, Vol. 16 Issue: 4 p258-265, 8p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Correction to: Diagnostic and therapeutic use of oral micronized progesterone in endocrinology.

Autor: Memi E; Unit of Endocrinology, Diabetes mellitus, and Metabolism, Aretaieion Hospital, School of Medicine, National and Kapodistrian University of Athens, Vas. Sophias Av. 76, Athens, 11528, Greece., Pavli P; Unit of Endocrinology, Diabetes mellitus, and Metabolism, Aretaieion Hospital, School of Medicine, National and Kapodistrian University of Athens, Vas. Sophias Av. 76, Athens, 11528, Greece., Papagianni M; Department of Nutrition and Dietetics, School of Physical Education, Sport Science and Dietetics, University of Thessaly, Trikala, 42100, Greece.; Endocrine Unit, 3rd Department of Pediatrics, Hippokration Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki, 54642, Greece., Vrachnis N; Third Department of Obstetrics and Gynecology, Attikon General Hospital, School of Medicine, National and Kapodistrian University of Athens, Rimini Str. 1, Chaidari, Athens, 12462, Greece.; St George's NHS Foundation Trust Teaching Hospitals, St George's University of London, London, UK., Mastorakos G; Unit of Endocrinology, Diabetes mellitus, and Metabolism, Aretaieion Hospital, School of Medicine, National and Kapodistrian University of Athens, Vas. Sophias Av. 76, Athens, 11528, Greece. mastorakg@gmail.com.

Publikováno v: Reviews in endocrine & metabolic disorders [Rev Endocr Metab Disord] 2024 Jun 26. Date of Electronic Publication: 2024 Jun 26.